Drug Utilization Over Time for Six Drug Classes

    Basic Details
    Date Posted
    Wednesday, March 9, 2022
    Status
    Complete
    Medical Product
    ace inhibitors
    beta blockers
    granulocyte colony-stimulating factor (GC-SF)
    intravenous (IV) iron
    statins
    tumor necrosis factor (TNF) alpha inhibitor
    Description

    This query investigated the use of tumor necrosis factor (TNF) alpha inhibitor drugs, granulocyte colony-stimulating factor (GC-SF) drugs, intravenous iron, statin drugs, angiotensin converting enzyme (ACE) inhibitor drugs, and beta blocker drugs. The study period includes data from January 1, 2011 to December 31, 2015. We distributed the request for TNF alpha inhibitor drugs, GC-SF drugs, and intravenous iron to 16 Sentinel Data Partners on August 10, 2016. We distributed the request for statin drugs, ACE inhibitor drugs, and beta blocker drugs to 15 Sentinel Data Partners on June 17, 2016.

    Additional Details
    FDA Center
    CDER
    Time Period
    January 1, 2011 - December 31, 2015
    Study Type
    Modular Program
    Assessment Type
    Exploratory Analyses
    Population / Cohort
    All individuals
    Data Sources
    Sentinel Distributed Database (SDD)